US7641780B2
(en)
*
|
2001-05-01 |
2010-01-05 |
Calibrant Biosystems, Inc. |
Two-dimensional microfluidics for protein separations and gene analysis
|
PT1601450E
(pt)
|
2003-03-10 |
2013-09-06 |
Expression Pathology Inc |
Preparação líquida de tecido a partir de amostras biológicas, de tecidos e de células tratados histopatologicamente
|
US7381440B2
(en)
*
|
2003-06-06 |
2008-06-03 |
The United States Of America As Represented By The Secretary Of The Navy |
Biological laser printing for tissue microdissection via indirect photon-biomaterial interactions
|
US8012693B2
(en)
|
2003-12-16 |
2011-09-06 |
3M Innovative Properties Company |
Analysis of chemically crosslinked cellular samples
|
DE102005023011A1
(de)
*
|
2005-05-19 |
2006-11-23 |
Qiagen Gmbh |
Quantitative Proteinbestimmung von Formalin fixiertem Gewebe
|
EP1883705A4
(en)
*
|
2005-05-25 |
2009-02-25 |
Expression Pathology Inc |
MULTIPLEX PROCESS FOR INCREASING PROTEOMIC COVERAGE FROM HISTOPATHOLOGICALLY TREATED BIOLOGICAL SAMPLES USING LIQUID TISSUE PREPARATIONS
|
EP1907845A4
(en)
*
|
2005-05-25 |
2009-03-04 |
Expression Pathology Inc |
DIAGNOSIS OF ILLNESSES AND SUFFERING BY ANALYSIS OF HISTOPATHOLOGICALLY PREPARED BIOLOGICAL SAMPLES USING LIQUID TISSUE PREPARATIONS
|
WO2006130632A2
(en)
*
|
2005-05-31 |
2006-12-07 |
Invitrogen Corporation |
Separation and purification of nucleic acid from paraffin-containing samples
|
DE102005027172A1
(de)
|
2005-06-13 |
2006-12-14 |
Merck Patent Gmbh |
Verwendung von Ionischen Flüssigkeiten zur Proteinextraktion
|
AU2006261624B2
(en)
*
|
2005-06-16 |
2012-02-02 |
Solventum Intellectual Properties Company |
Method of classifying chemically crosslinked cellular samples using mass spectra
|
DE102005060738A1
(de)
*
|
2005-12-16 |
2007-06-21 |
Qiagen Gmbh |
Verfahren zur Extraktion von Biomolekülen aus fixierten Geweben
|
WO2007112350A2
(en)
*
|
2006-03-24 |
2007-10-04 |
Expression Pathology |
Method of assessing the metastatic status of a primary tumor
|
JP2008043332A
(ja)
*
|
2006-08-17 |
2008-02-28 |
Panomics Inc |
組織スライドからの核酸定量
|
US20100075372A1
(en)
*
|
2006-09-28 |
2010-03-25 |
Taka-Aki Sato |
Method for deparaffinization of paraffin-embedded specimen and method for analysis of paraffin-embedded specimen
|
US20080160629A1
(en)
*
|
2007-01-02 |
2008-07-03 |
Calibrant Biosystems, Inc. |
Methods and systems for off-line multidimensional concentration and separation of biomolecules
|
US20080156080A1
(en)
*
|
2007-01-02 |
2008-07-03 |
Calibrant Biosystems, Inc. |
Methods and systems for multidimensional concentration and separation of biomolecules using capillary isotachophoresis
|
WO2009012353A2
(en)
|
2007-07-19 |
2009-01-22 |
Boston Scientific Limited |
Endoprosthesis having a non-fouling surface
|
JP2010535541A
(ja)
|
2007-08-03 |
2010-11-25 |
ボストン サイエンティフィック リミテッド |
広い表面積を有する医療器具用のコーティング
|
WO2009131911A2
(en)
|
2008-04-22 |
2009-10-29 |
Boston Scientific Scimed, Inc. |
Medical devices having a coating of inorganic material
|
WO2009132176A2
(en)
|
2008-04-24 |
2009-10-29 |
Boston Scientific Scimed, Inc. |
Medical devices having inorganic particle layers
|
EP2193831A1
(de)
*
|
2008-12-05 |
2010-06-09 |
Qiagen GmbH |
Parallel-Extraktion von unterschiedlichen Biomolekülen aus Formalin-fixiertem Gewebe
|
DE102009031434B4
(de)
*
|
2009-07-01 |
2015-03-05 |
Axagarius Gmbh & Co. Kg |
Verwendung eines Kits für die Isolierung von Biomolekülen aus biologischen Proben sowie Kit hierfür
|
CA2785552C
(en)
*
|
2009-12-22 |
2018-02-27 |
Expression Pathology, Inc. |
Insulin-like growth factor 1 receptor (igf-1r) protein srm/mrm assay
|
WO2011087862A1
(en)
*
|
2009-12-22 |
2011-07-21 |
Expression Pathology, Inc. |
Insulin receptor substrate 1 (irs1) protein srm/mrm assay
|
EP3267194B1
(en)
|
2009-12-22 |
2019-06-05 |
Expression Pathology, Inc. |
Secreted protein acidic and rich in cysteine (sparc) protein srm/mrm assay
|
AU2010341485B2
(en)
*
|
2009-12-22 |
2016-11-17 |
Expression Pathology, Inc. |
Epidermal growth factor receptor (EGFR) protein SRM/MRM assay
|
US10787701B2
(en)
|
2010-04-05 |
2020-09-29 |
Prognosys Biosciences, Inc. |
Spatially encoded biological assays
|
US20190300945A1
(en)
|
2010-04-05 |
2019-10-03 |
Prognosys Biosciences, Inc. |
Spatially Encoded Biological Assays
|
JP2013528284A
(ja)
*
|
2010-05-26 |
2013-07-08 |
エクスプレッション、パソロジー、インコーポレイテッド |
ウロキナーゼ型プラスミノーゲン活性化因子タンパク質/プラスミノーゲン活性化因子阻害物質1型タンパク質選択反応モニタリングアッセイ
|
AU2011282546B2
(en)
*
|
2010-07-30 |
2016-11-17 |
Expression Pathology, Inc. |
c-Src selected reaction monitoring assay
|
US9427410B2
(en)
|
2010-10-08 |
2016-08-30 |
The University Of North Carolina At Chapel Hill |
Formulation of acoustically activatable particles having low vaporization energy and methods for using same
|
ES2750326T3
(es)
|
2010-12-27 |
2020-03-25 |
Expression Pathology Inc |
Ensayo SRM/MRM de proteína c-MET
|
AU2012205337B2
(en)
|
2011-01-13 |
2017-04-13 |
Expression Pathology, Inc. |
Bcl-2-like protein 11 SRM/MRM assay
|
CN102146112B
(zh)
*
|
2011-01-25 |
2013-07-10 |
天根生化科技(北京)有限公司 |
从福尔马林固定石蜡包埋组织中提取脱氧核糖核酸的方法
|
US9372196B2
(en)
|
2011-03-08 |
2016-06-21 |
Bioproximity, Llc |
Formalin-fixed isotope-labeled reference standards and methods for fabrication and use thereof
|
GB201106254D0
(en)
|
2011-04-13 |
2011-05-25 |
Frisen Jonas |
Method and product
|
ES2649977T3
(es)
|
2011-09-22 |
2018-01-16 |
Expression Pathology, Inc. |
Ensayo MRM/SRM para la proteína receptor de muerte 5
|
CA3045682A1
(en)
|
2011-09-22 |
2013-03-28 |
Expression Pathology, Inc. |
Multiplex mrm assay for evaluation of cancer
|
JP6073337B2
(ja)
|
2011-10-04 |
2017-02-01 |
エクスプレッション、パソロジー、インコーポレイテッドExpression Pathology, Inc. |
レセプター型チロシンキナーゼerbB−4タンパク質(HER4)に対するSRM/MRMアッセイ
|
EP2788484B1
(en)
|
2011-12-06 |
2017-11-01 |
Qiagen GmbH |
Recovery of a biomolecule comprising aqueous phase from a multiphasic mixture
|
AU2013207952B2
(en)
*
|
2012-01-10 |
2017-03-09 |
Expression Pathology, Inc. |
SRM/MRM assay for the insulin receptor protein
|
CN103207107B
(zh)
*
|
2012-01-16 |
2016-09-07 |
中国医学科学院北京协和医院 |
硝酸纤维素膜富集体液蛋白质组蛋白的用途
|
EP2850229A4
(en)
|
2012-05-16 |
2016-02-17 |
Expression Pathology Inc |
SRM / MRM METHOD FOR HISTOLOGICAL SUBTYPING OF PULMONARY TUMORS
|
US9982290B2
(en)
*
|
2012-10-04 |
2018-05-29 |
The University Of North Carolina At Chapel Hill |
Methods and systems for using encapsulated microbubbles to process biological samples
|
EP2730653A1
(en)
|
2012-11-07 |
2014-05-14 |
QIAGEN GmbH |
Method for lysing a fixed biological sample
|
EP3474014B1
(en)
|
2013-03-15 |
2020-06-17 |
Expression Pathology, Inc. |
Srm assay to indicate cancer therapy
|
CA2916660C
(en)
|
2013-06-25 |
2022-05-17 |
Prognosys Biosciences, Inc. |
Spatially encoded biological assays using a microfluidic device
|
JP2017503503A
(ja)
|
2014-01-06 |
2017-02-02 |
エクスプレッション、パソロジー、インコーポレイテッド |
Pd−l1に対するsrmアッセイ
|
JP6668256B2
(ja)
*
|
2014-04-30 |
2020-03-25 |
エクスプレッション、パソロジー、インコーポレイテッドExpression Pathology, Inc. |
チロシンプロテインキナーゼ受容体ufo(axl)タンパク質のsrm/mrmアッセイ
|
EP3137632B1
(en)
|
2014-04-30 |
2020-03-25 |
Expression Pathology, Inc. |
Srm/mrm assay for the androgen receptor (ar) protein
|
WO2016004233A2
(en)
|
2014-07-01 |
2016-01-07 |
Expression Pathology, Inc. |
Srm assays to chemotherapy targets
|
CN106489075B
(zh)
*
|
2014-07-11 |
2019-10-15 |
爱科谱迅病理研究公司 |
针对GTP酶KRas蛋白质(KRas)的SRM/MRM测定
|
US20190099475A1
(en)
|
2015-04-08 |
2019-04-04 |
Nantomics, Llc |
Cancer neoepitopes
|
US10774374B2
(en)
|
2015-04-10 |
2020-09-15 |
Spatial Transcriptomics AB and Illumina, Inc. |
Spatially distinguished, multiplex nucleic acid analysis of biological specimens
|
CA2988388C
(en)
|
2015-04-23 |
2022-11-22 |
Nantomics, Llc |
Cancer neoepitopes
|
CA2986120A1
(en)
|
2015-05-14 |
2016-11-17 |
Expression Pathology, Inc. |
Srm/mrm assay for the mesothelin (msln) protein
|
WO2016183597A1
(en)
*
|
2015-05-14 |
2016-11-17 |
Expression Pathology, Inc. |
Srm/mrm assay for the fibroblast growth factor receptor 2 (fgfr2) protein
|
US10060927B2
(en)
|
2015-05-14 |
2018-08-28 |
Expression Pathology, Inc. |
SRM/MRM assay for the 6-O-methylguanine-DNA methyltransferase (MGMT) protein
|
KR102062149B1
(ko)
|
2015-05-22 |
2020-01-03 |
익스프레션 패톨로지, 인크. |
사이클린-의존성 키나제 억제제 2A(p16) 단백질에 대한 SRM/MRM 분석법
|
EP3304072A4
(en)
|
2015-05-29 |
2018-12-05 |
Expression Pathology, Inc. |
Quantifying her2 protein for optimal cancer therapy
|
CN108135902A
(zh)
|
2015-07-30 |
2018-06-08 |
爱科谱迅病理研究公司 |
用于最优癌症治疗的定量FR-α和GART蛋白质
|
WO2017053983A1
(en)
|
2015-09-24 |
2017-03-30 |
Expression Pathology, Inc. |
Quantifying met protein for cancer treatment
|
AU2016339022B2
(en)
|
2015-10-12 |
2020-09-10 |
Nantomics, Llc |
Iterative discovery of neoepitopes and adaptive immunotherapy and methods therefor
|
CN108701173A
(zh)
|
2015-10-12 |
2018-10-23 |
南托米克斯有限责任公司 |
用于发现预测对检查点抑制剂敏感的msi和新表位的系统、组合物和方法
|
CA3003302A1
(en)
|
2015-10-12 |
2017-04-20 |
Nantomics, Llc |
Compositions and methods for viral cancer neoepitopes
|
TWI733719B
(zh)
|
2015-12-07 |
2021-07-21 |
美商河谷控股Ip有限責任公司 |
改善的組合物及用於新表位之病毒遞送的方法及其應用
|
EP3414692A4
(en)
|
2016-02-12 |
2020-07-29 |
Nantomics, LLC |
HIGH-RATE IDENTIFICATION OF PATIENT-SPECIFIC NEOEPITOPES AS THERAPEUTIC TARGETS FOR CANCER IMMUNOTHERAPIES
|
JP2019513021A
(ja)
|
2016-03-24 |
2019-05-23 |
ナントセル,インコーポレイテッド |
ネオエピトープ提示のための配列の配置および配列
|
PL3222719T3
(pl)
*
|
2016-03-24 |
2020-09-21 |
Allflex Europe Sa |
Zastosowanie wodnej kompozycji do rozpuszczania biomolekuł z próbki tkanki
|
US20180172690A1
(en)
*
|
2016-04-20 |
2018-06-21 |
Expression Pathology, Inc. |
Method for improved hepatocellular cancer diagnosis
|
EP3463452A1
(en)
|
2016-05-24 |
2019-04-10 |
Institut National de la Sante et de la Recherche Medicale (INSERM) |
Methods and pharmaceutical compositions for the treatment of non small cell lung cancer (nsclc) that coexists with chronic obstructive pulmonary disease (copd)
|
EP3500966B1
(en)
|
2016-08-25 |
2021-04-21 |
Nantomics, LLC |
Immunotherapy markers and uses therefor
|
US20190321481A1
(en)
|
2016-11-11 |
2019-10-24 |
Nantbio, Inc. |
Immunomodulatory compositions, processes for making the same, and methods for inhibiting cytokine storms
|
CN110214275B
(zh)
|
2016-12-01 |
2022-12-06 |
南托米克斯有限责任公司 |
肿瘤抗原性加工和呈递
|
US10617717B2
(en)
|
2016-12-04 |
2020-04-14 |
Expression Pathology, Inc. |
Methods of treating lung cancer by predicting responders to cisplatin-pemetrexed combination therapy
|
WO2018122249A1
(en)
|
2016-12-28 |
2018-07-05 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting the survival time of patients suffering from a microsatellite stable colorectal cancer
|
WO2018122245A1
(en)
|
2016-12-28 |
2018-07-05 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods of predicting the survival time of patients suffering from cms3 colorectal cancer
|
AU2018226852A1
(en)
*
|
2017-03-03 |
2019-10-17 |
Expression Pathology, Inc. |
Immune profiling of tumor tissue
|
SG11201909882SA
(en)
|
2017-04-24 |
2019-11-28 |
Nantcell Inc |
Targeted neoepitope vectors and methods therefor
|
US20200150109A1
(en)
|
2017-05-05 |
2020-05-14 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Microtubule-targeting drugs as immune checkpoint inhibitors and methods of screening novel immune checkpoint inhibitors for the treatment of cancers and infectious diseases
|
EP3631471A4
(en)
|
2017-05-30 |
2021-06-30 |
Nant Holdings IP, LLC |
ENRICHMENT OF CIRCULATING TUMOR CELLS USING NEO-EPITOPIA
|
US10722509B2
(en)
|
2018-01-16 |
2020-07-28 |
Nantomics, Llc |
Predicting optimal chemotherapy for CRC
|
US10725045B2
(en)
|
2018-02-13 |
2020-07-28 |
Nantomics, Llc |
Quantifying MGMT protein for optimal cancer therapy of glioblastoma
|
US10722531B2
(en)
|
2018-02-13 |
2020-07-28 |
Nantomics, Llc |
OPRT expression and cancer treatment outcome
|
AU2019201463A1
(en)
|
2018-03-09 |
2019-09-26 |
Nantomics, Llc |
Srm/mrm assays for profiling tumor tissue
|
US20190353660A1
(en)
|
2018-05-17 |
2019-11-21 |
Nantomics, Llc |
Identification of cancer patients sensitive or resistant to 5-fluorouracil (5-fu)
|
KR20200050374A
(ko)
|
2018-10-30 |
2020-05-11 |
익스프레션 패톨로지, 인크. |
노치 경로 단백질용 srm/mrm 분석
|
EP3894591A2
(en)
|
2018-12-10 |
2021-10-20 |
10X Genomics, Inc. |
Imaging system hardware
|
EP3906415A1
(en)
|
2019-01-03 |
2021-11-10 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for enhancing cd8+ t cell-dependent immune responses in subjects suffering from cancer
|
US11926867B2
(en)
|
2019-01-06 |
2024-03-12 |
10X Genomics, Inc. |
Generating capture probes for spatial analysis
|
US11649485B2
(en)
|
2019-01-06 |
2023-05-16 |
10X Genomics, Inc. |
Generating capture probes for spatial analysis
|
KR20200087700A
(ko)
|
2019-01-11 |
2020-07-21 |
난토믹스, 엘엘씨 |
질량 분석법에 의한 sdhb 단백질 발현의 평가
|
JP2022527972A
(ja)
|
2019-04-02 |
2022-06-07 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
前悪性病変を有する患者において癌を予測及び予防する方法
|
EP3952850A1
(en)
|
2019-04-09 |
2022-02-16 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Use of sk2 inhibitors in combination with immune checkpoint blockade therapy for the treatment of cancer
|
SG11202112712RA
(en)
|
2019-06-03 |
2021-12-30 |
Inst Nat Sante Rech Med |
Methods for modulating a treatment regimen
|
JP7215467B2
(ja)
*
|
2019-08-19 |
2023-01-31 |
株式会社島津製作所 |
ホルマリン固定パラフィン包埋組織試料からの抗体の分離、検出及び/又は分析方法
|
WO2021074391A1
(en)
|
2019-10-17 |
2021-04-22 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for diagnosing nasal intestinal type adenocarcinomas
|
EP4045912A1
(en)
|
2019-10-18 |
2022-08-24 |
Reccan Diagnostics AB |
Apparatuses and methods for detection of pancreatic cancer
|
WO2021092433A2
(en)
|
2019-11-08 |
2021-05-14 |
10X Genomics, Inc. |
Enhancing specificity of analyte binding
|
DK3891300T3
(da)
|
2019-12-23 |
2023-05-22 |
10X Genomics Inc |
Fremgangsmåder til rumlig analyse ved anvendelse af rna-template-ligering
|
EP4081777A1
(en)
|
2019-12-23 |
2022-11-02 |
10X Genomics, Inc. |
Reversible fixing reagents and methods of use thereof
|
EP4081656A1
(en)
|
2019-12-23 |
2022-11-02 |
10X Genomics, Inc. |
Compositions and methods for using fixed biological samples in partition-based assays
|
US11732299B2
(en)
|
2020-01-21 |
2023-08-22 |
10X Genomics, Inc. |
Spatial assays with perturbed cells
|
US11702693B2
(en)
|
2020-01-21 |
2023-07-18 |
10X Genomics, Inc. |
Methods for printing cells and generating arrays of barcoded cells
|
US11898205B2
(en)
|
2020-02-03 |
2024-02-13 |
10X Genomics, Inc. |
Increasing capture efficiency of spatial assays
|
US11732300B2
(en)
|
2020-02-05 |
2023-08-22 |
10X Genomics, Inc. |
Increasing efficiency of spatial analysis in a biological sample
|
US11891654B2
(en)
|
2020-02-24 |
2024-02-06 |
10X Genomics, Inc. |
Methods of making gene expression libraries
|
US11926863B1
(en)
|
2020-02-27 |
2024-03-12 |
10X Genomics, Inc. |
Solid state single cell method for analyzing fixed biological cells
|
US20230113705A1
(en)
|
2020-02-28 |
2023-04-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for diagnosing, prognosing and managing treatment of breast cancer
|
EP4127164A1
(en)
|
2020-03-31 |
2023-02-08 |
QIAGEN GmbH |
Nucleic acid purification from fixed biological samples
|
WO2021207610A1
(en)
|
2020-04-10 |
2021-10-14 |
10X Genomics, Inc. |
Cold protease treatment method for preparing biological samples
|
CN115916972A
(zh)
|
2020-04-16 |
2023-04-04 |
10X基因组学有限公司 |
用于被固定样品的组合物和方法
|
CN115916999A
(zh)
|
2020-04-22 |
2023-04-04 |
10X基因组学有限公司 |
用于使用靶向rna耗竭进行空间分析的方法
|
AU2021275906A1
(en)
|
2020-05-22 |
2022-12-22 |
10X Genomics, Inc. |
Spatial analysis to detect sequence variants
|
EP4153775A1
(en)
|
2020-05-22 |
2023-03-29 |
10X Genomics, Inc. |
Simultaneous spatio-temporal measurement of gene expression and cellular activity
|
WO2021252499A1
(en)
|
2020-06-08 |
2021-12-16 |
10X Genomics, Inc. |
Methods of determining a surgical margin and methods of use thereof
|
AU2021294334A1
(en)
|
2020-06-25 |
2023-02-02 |
10X Genomics, Inc. |
Spatial analysis of DNA methylation
|
JP2023531290A
(ja)
|
2020-06-30 |
2023-07-21 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
術前補助療法及び根治手術後の固形がんを患っている患者の再発及び/又は死亡のリスクを予測するための方法
|
US20230235408A1
(en)
|
2020-06-30 |
2023-07-27 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting the risk of recurrence and/or death of patients suffering from a solid cancer after preoperative adjuvant therapies
|
US11761038B1
(en)
|
2020-07-06 |
2023-09-19 |
10X Genomics, Inc. |
Methods for identifying a location of an RNA in a biological sample
|
US20230287475A1
(en)
|
2020-07-31 |
2023-09-14 |
10X Genomics, Inc. |
De-crosslinking compounds and methods of use for spatial analysis
|
US11926822B1
(en)
|
2020-09-23 |
2024-03-12 |
10X Genomics, Inc. |
Three-dimensional spatial analysis
|
WO2022103712A1
(en)
|
2020-11-13 |
2022-05-19 |
10X Genomics, Inc. |
Nano-partitions (encapsulated nucleic acid processing enzymes) for cell-lysis and multiple reactions in partition-based assays
|
US11827935B1
(en)
|
2020-11-19 |
2023-11-28 |
10X Genomics, Inc. |
Methods for spatial analysis using rolling circle amplification and detection probes
|
EP4121555A1
(en)
|
2020-12-21 |
2023-01-25 |
10X Genomics, Inc. |
Methods, compositions, and systems for capturing probes and/or barcodes
|
JP2024512567A
(ja)
|
2021-03-23 |
2024-03-19 |
インサーム(インスティテュ ナシオナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシェ メディカル) |
T細胞リンパ腫の診断および治療方法
|
EP4196605A1
(en)
|
2021-09-01 |
2023-06-21 |
10X Genomics, Inc. |
Methods, compositions, and kits for blocking a capture probe on a spatial array
|
WO2023121449A1
(en)
|
2021-12-21 |
2023-06-29 |
Koninklijke Nederlandse Akademie Van Wetenschappen |
Central nervous system organoids
|
WO2023144303A1
(en)
|
2022-01-31 |
2023-08-03 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Cd38 as a biomarker and biotarget in t-cell lymphomas
|
WO2023175366A1
(en)
|
2022-03-17 |
2023-09-21 |
Veracyte |
Methods for predicting response to an immunotherapeutic treatment in a patient with a cancer
|
WO2023198648A1
(en)
|
2022-04-11 |
2023-10-19 |
Institut National de la Santé et de la Recherche Médicale |
Methods for the diagnosis and treatment of t-cell malignancies
|
WO2023198874A1
(en)
|
2022-04-15 |
2023-10-19 |
Institut National de la Santé et de la Recherche Médicale |
Methods for the diagnosis and treatment of t cell-lymphomas
|
US20240035071A1
(en)
|
2022-06-17 |
2024-02-01 |
10X Genomics, Inc. |
Catalytic de-crosslinking of samples for in situ analysis
|
WO2024003310A1
(en)
|
2022-06-30 |
2024-01-04 |
Institut National de la Santé et de la Recherche Médicale |
Methods for the diagnosis and treatment of acute lymphoblastic leukemia
|
WO2024018046A1
(en)
|
2022-07-22 |
2024-01-25 |
Institut National de la Santé et de la Recherche Médicale |
Garp as a biomarker and biotarget in t-cell malignancies
|
WO2024023283A1
(en)
|
2022-07-29 |
2024-02-01 |
Institut National de la Santé et de la Recherche Médicale |
Lrrc33 as a biomarker and biotarget in cutaneous t-cell lymphomas
|